Market Cap (In HKD)
1.59 Billion
Revenue (In HKD)
336.21 Million
Net Income (In HKD)
-471.53 Million
Avg. Volume
3.74 Million
- Currency
- HKD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.58-1.65
- PE
- -
- EPS
- -
- Beta Value
- 0.464
- ISIN
- KYG6082P1054
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Jeffrey R Lindstrom
- Employee Count
- -
- Website
- https://www.cardioflowmedtech.com
- Ipo Date
- 2021-02-04
- Details
- MicroPort CardioFlow Medtech Corporation, a medical device company, researches, develops, and commercializes transcatheter and surgical solutions for structural heart diseases in the People's Republic of China. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set to target aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was founded in 2010 and is headquartered in Shanghai, China.
More Stocks
-
HRME
-
0QKURoyal Bank of Canada
0QKU
-
IMPC
-
SAH
-
STT-PGState Street Corporation
STT-PG
-
SMBC
-
TLPPF
-
TAPG